Zhaoyun Liu Selected Research

Indicators and Reagents (Reagents)

1/2024	The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy.
1/2023	The value of serum IL-4 to predict the survival of MDS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaoyun Liu Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 02/2015
16	Multiple Myeloma 02/2024 - 04/2018
14	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2017
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 10/2016
6	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 02/2023 - 03/2018
6	Triple Negative Breast Neoplasms 01/2020 - 02/2015
5	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2021
4	Disease Progression 02/2023 - 01/2020
3	Bone Diseases (Bone Disease) 01/2023 - 11/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 04/2018
2	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 06/2023
2	Anemia 01/2023 - 02/2022
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 06/2019
2	Iron Overload 04/2020 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2019
2	Bronchopulmonary Dysplasia 02/2015 - 01/2015
2	Hyperoxia 02/2015 - 01/2015
1	Residual Neoplasm 01/2024
1	Immune System Diseases (Immune Disorders) 11/2023
1	Bone Marrow Failure Disorders 07/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Abscess 01/2023
1	Infections 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 01/2020
4	Trastuzumab (Herceptin)FDA Link 01/2024 - 01/2021
4	Long Noncoding RNAIBA 02/2023 - 04/2019
3	IronIBA 06/2023 - 04/2020
3	Histones (Histone)IBA 05/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2020
3	pyrotinibIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
3	Gefitinib (Iressa)FDA Link 01/2020 - 02/2015
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 04/2018
3	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2019 - 10/2016
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2023
2	taxaneIBA 12/2023 - 10/2017
2	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2021
2	AnthracyclinesIBA 12/2023 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 11/2023 - 10/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2023 - 01/2023
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 10/2017
2	Immunoglobulins (Immunoglobulin)IBA 10/2022 - 04/2021
2	Thrombopoietin ReceptorsIBA 01/2022 - 01/2020
2	eltrombopag FDA Link 01/2022 - 01/2020
2	fibrin fragment D (D-dimer)IBA 01/2022 - 06/2019
2	Histone Deacetylase InhibitorsIBA 01/2019 - 10/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 02/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2024
1	Bortezomib (Velcade)FDA Link 02/2024
1	Immunoconjugates (Immunoconjugate)IBA 01/2024
1	disitamab vedotinIBA 01/2024
1	Formaldehyde (Formol)FDA Link 12/2023
1	ParaffinIBA 12/2023
1	NucleotidesIBA 12/2023
1	Lactate Dehydrogenase 5IBA 11/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023
1	pertuzumabIBA 09/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2023
1	Surface Antigens (Surface Antigen)IBA 07/2023
1	Glycyrrhetinic Acid (Po 12)IBA 06/2023
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 06/2023
1	Metal-Organic FrameworksIBA 06/2023
1	ChitosanIBA 06/2023
1	LigandsIBA 05/2023
1	Polycomb Repressive Complex 2IBA 05/2023
1	Monoclonal AntibodiesIBA 05/2023
1	Lysine (L-Lysine)FDA Link 05/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2023
1	Acetyl-CoA CarboxylaseIBA 04/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 04/2023
1	EnzymesIBA 04/2023
1	Bovine Serum AlbuminIBA 02/2023
1	Photosensitizing Agents (Photosensitizers)IBA 02/2023
1	LipidsIBA 02/2023
1	roxadustatIBA 01/2023
1	cyperotundoneIBA 01/2023
1	ruxolitinibIBA 01/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	hydroxide ionIBA 01/2023
1	Methicillin (Metin)FDA Link 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	AntigensIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	GlycosphingolipidsIBA 01/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	CEACAM1 ProteinIBA 01/2023

Therapy/Procedure

16	Therapeutics 01/2024 - 11/2015
8	Immunotherapy 03/2024 - 01/2020
4	Drug Therapy (Chemotherapy) 12/2023 - 01/2021
3	Radiotherapy 03/2024 - 12/2021
3	Neoadjuvant Therapy 01/2024 - 09/2023
2	Microspheres (Microsphere) 11/2023 - 06/2023
1	Lasers (Laser) 04/2023
1	Treatment Delay 01/2023